Deseret Mutual Benefit Administrators’s Thermo Fisher Scientific TMO Stock Holding History

Deseret Mutual Benefit Administrators’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Sell	721 -54	-7%	-$25.9K	0.12%	132
2026 Q1	$381K	Buy	775 +383	+98%	+$208K	0.13%	133
2025 Q4	$227K	Hold	392	–	–	0.1%	123
2025 Q3	$190K	Buy	392 +78	+25%	+$36.3K	0.08%	144
2025 Q2	$127K	Hold	314	–	–	0.06%	189
2025 Q1	$156K	Buy	314 +19	+6%	+$10.3K	0.08%	164
2024 Q4	$153K	Buy	295 +13	+5%	+$7.15K	0.08%	165
2024 Q3	$174K	Buy	282 +12	+4%	+$7.1K	0.09%	151
2024 Q2	$149K	Buy	270 +16	+6%	+$9.17K	0.07%	163
2024 Q1	$148K	Buy	254 +22	+9%	+$12.3K	0.07%	160
2023 Q4	$123K	Sell	232 -43	-16%	-$20.8K	0.07%	172
2023 Q3	$139K	Sell	275 -9	-3%	-$4.8K	0.07%	173
2023 Q2	$148K	Buy	284 +3	+1%	+$1.62K	0.06%	179
2023 Q1	$162K	Hold	281	–	–	0.06%	166
2022 Q4	$155K	Sell	281 -199	-41%	-$105K	0.06%	167
2022 Q3	$244K	Sell	480 -105	-18%	-$58.8K	0.07%	173
2022 Q2	$318K	Hold	585	–	–	0.07%	175
2022 Q1	$346K	Sell	585 -62	-10%	-$35.6K	0.07%	181
2021 Q4	$432K	Buy	647 +17	+3%	+$10.6K	0.07%	176
2021 Q3	$360K	Sell	630 -147	-19%	-$80.7K	0.07%	186
2021 Q2	$392K	Buy	+777	New	+$367K	0.1%	115

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Deseret Mutual Benefit Administrators's TMO Position: Q2 2026 in Review

Deseret Mutual Benefit Administrators reduced its Thermo Fisher Scientific (TMO) stake by 7% in Q2 2026, selling an estimated $25.9K and leaving 721 shares worth $361K. The position accounts for 0.12% of the portfolio, ranked #132.

Deseret Mutual Benefit Administrators first reported a position in TMO in Q2 2021 and has held it in 21 quarters since. The position peaked at $432K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Deseret Mutual Benefit Administrators held 721 shares of Thermo Fisher Scientific worth $361K as of Q2 2026.
Deseret Mutual Benefit Administrators sold 54 Thermo Fisher Scientific shares in Q2 2026, an estimated $25.9K.
Thermo Fisher Scientific made up 0.12% of Deseret Mutual Benefit Administrators's portfolio in Q2 2026, its #132 holding.
Deseret Mutual Benefit Administrators first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 21 quarters since.
Deseret Mutual Benefit Administrators's Thermo Fisher Scientific position peaked at $432K in Q4 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q2 2026, filed 14 Aug 2026.